ClinicalTrials.Veeva

Menu
G

Genesis Research Services | Newcastle, Australia

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Xanamem®
LY3009104
Baricitinib
Rimegepant

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 5 total trials

A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis (RA-BRIDGE)

This post-marketing study is designed to compare the safety of baricitinib versus tumor necrosis factor (TNF) inhibitors with respect to venous throm...

Active, not recruiting
Rheumatoid Arthritis
Drug: Baricitinib
Drug: TNF Inhibitor

This study is being conducted to evaluate the efficacy and tolerability of rimegepant for migraine prophylaxis in adults with a history of inadequate...

Enrolling
Migraine
Drug: Placebo
Drug: Rimegepant

The aim of this randomised, double-blind, placebo controlled clinical food trial is to determine if the medical food SBD121 Synbiotic (prebiotic and...

Enrolling
Rheumatoid Arthritis
Other: Placebo
Other: SBD121

Trial sponsors

A
Lilly logo
Pfizer logo
S
X

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems